The relevance of pharmacology in clinical oncology practice
- 1 June 1993
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 4 (6) , 463-469
- https://doi.org/10.1093/oxfordjournals.annonc.a058552
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- The impact of pharmacokinetically guided dose escalation strategies in phase I clinical trials: Critical evaluation and recommendations for future studiesAnnals of Oncology, 1992
- Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.Journal of Clinical Oncology, 1992
- Learning from Cl-941 about pharmacokinetically guided dose escalationEuropean Journal Of Cancer, 1992
- Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.Journal of Clinical Oncology, 1991
- Pharmacologically Guided Phase I Clinical Trials Based Upon Preclinical Drug DevelopmentJNCI Journal of the National Cancer Institute, 1990
- Does chemotherapy fulfill its expectations in cancer treatment?Annals of Oncology, 1990
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Pharmacokinetically guided dose escalation in phase I clinical trials. Commentary and proposed guidelinesEuropean Journal of Cancer and Clinical Oncology, 1987